Phillip Pang, Chief Medical Officer at Vir Biotechnology, Inc. (VIR), sold 10,320 shares at $23.00 ($238K) on 2023-02-27, disclosed to the SEC on 2023-02-28.
Open-market sale of $238k VIR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.00 | 8,920 | $205K | 86.1% |
| 2 | $23.56 | 1,400 | $33K | 13.9% |
| Total | $23.08 avg | 10,320 | $238K | 100% |
| Filing → |
| VIR | SELL | 2023-06-08 | $130K | — | Filing → |
| VIR | SELL | 2023-02-24 | $149K | — | Filing → |
| VIR | SELL | 2023-02-21 | $142K | — | Filing → |